Annual EBIT
-$106.85 M
+$19.00 M+15.10%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual earnings before interest & taxes is -$106.85 million, with the most recent change of +$19.00 million (+15.10%) on September 30, 2024.
- During the last 3 years, ENTA annual EBIT has risen by +$731.00 thousand (+0.68%).
- ENTA annual EBIT is now -185.16% below its all-time high of $125.46 million, reached on September 30, 2015.
Performance
ENTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$26.61 M
-$5.91 M-28.54%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly earnings before interest & taxes is -$26.61 million, with the most recent change of -$5.91 million (-28.54%) on September 30, 2024.
- Over the past year, ENTA quarterly EBIT has dropped by -$239.00 thousand (-0.91%).
- ENTA quarterly EBIT is now -137.73% below its all-time high of $70.51 million, reached on December 31, 2014.
Performance
ENTA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$106.85 M
-$239.00 K-0.22%
September 30, 2024
Summary
- As of February 8, 2025, ENTA TTM earnings before interest & taxes is -$106.85 million, with the most recent change of -$239.00 thousand (-0.22%) on September 30, 2024.
- Over the past year, ENTA TTM EBIT has increased by +$19.00 million (+15.10%).
- ENTA TTM EBIT is now -171.64% below its all-time high of $149.14 million, reached on March 31, 2015.
Performance
ENTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ENTA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.1% | -0.9% | +15.1% |
| 3 y3 years | +0.7% | +16.2% | +0.7% |
| 5 y5 years | -390.8% | +16.2% | +0.7% |
ENTA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.1% | -28.5% | +29.3% | -0.2% | +17.7% |
| 5 y | 5-year | -390.8% | +15.1% | -306.7% | +29.3% | -591.2% | +17.7% |
| alltime | all time | -185.2% | +15.1% | -137.7% | +29.3% | -171.6% | +17.7% |
Enanta Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$106.85 M(-15.1%) | -$26.61 M(+28.5%) | -$106.85 M(+0.2%) |
| Jun 2024 | - | -$20.70 M(-28.5%) | -$106.61 M(-10.2%) |
| Mar 2024 | - | -$28.96 M(-5.3%) | -$118.76 M(-6.8%) |
| Dec 2023 | - | -$30.59 M(+16.0%) | -$127.42 M(+1.2%) |
| Sep 2023 | -$125.85 M(+3.0%) | -$26.37 M(-19.7%) | -$125.85 M(+0.0%) |
| Jun 2023 | - | -$32.85 M(-12.7%) | -$125.81 M(+0.6%) |
| Mar 2023 | - | -$37.61 M(+29.6%) | -$125.11 M(+3.1%) |
| Dec 2022 | - | -$29.02 M(+10.2%) | -$121.35 M(-1.1%) |
| Sep 2022 | -$122.19 M(+13.6%) | -$26.33 M(-18.1%) | -$122.74 M(-4.2%) |
| Jun 2022 | - | -$32.15 M(-5.0%) | -$128.14 M(-1.3%) |
| Mar 2022 | - | -$33.85 M(+11.3%) | -$129.84 M(+3.3%) |
| Dec 2021 | - | -$30.41 M(-4.2%) | -$125.69 M(+16.8%) |
| Sep 2021 | -$107.58 M(+158.4%) | -$31.73 M(-6.2%) | -$107.58 M(+12.5%) |
| Jun 2021 | - | -$33.85 M(+14.0%) | -$95.63 M(+13.0%) |
| Mar 2021 | - | -$29.70 M(+141.5%) | -$84.63 M(+26.7%) |
| Dec 2020 | - | -$12.30 M(-37.8%) | -$66.81 M(+60.4%) |
| Sep 2020 | -$41.64 M(-213.3%) | -$19.78 M(-13.4%) | -$41.64 M(+169.9%) |
| Jun 2020 | - | -$22.85 M(+92.4%) | -$15.43 M(-237.9%) |
| Mar 2020 | - | -$11.88 M(-192.3%) | $11.18 M(-48.6%) |
| Dec 2019 | - | $12.87 M(+100.1%) | $21.75 M(-40.8%) |
| Sep 2019 | $36.74 M(-58.4%) | $6.43 M(+71.3%) | $36.74 M(-43.3%) |
| Jun 2019 | - | $3.75 M(-388.0%) | $64.76 M(-22.6%) |
| Mar 2019 | - | -$1.30 M(-104.7%) | $83.64 M(-17.8%) |
| Dec 2018 | - | $27.86 M(-19.1%) | $101.81 M(+15.3%) |
| Sep 2018 | $88.33 M | $34.45 M(+52.2%) | $88.33 M(-18.3%) |
| Jun 2018 | - | $22.64 M(+34.3%) | $108.17 M(+49.4%) |
| Mar 2018 | - | $16.86 M(+17.3%) | $72.40 M(+57.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $14.38 M(-73.5%) | $46.04 M(+83.0%) |
| Sep 2017 | $24.61 M(-20.2%) | $54.30 M(-513.6%) | $25.15 M(-175.0%) |
| Jun 2017 | - | -$13.13 M(+38.1%) | -$33.53 M(+59.4%) |
| Mar 2017 | - | -$9.51 M(+46.0%) | -$21.03 M(+81.2%) |
| Dec 2016 | - | -$6.51 M(+48.6%) | -$11.60 M(-137.6%) |
| Sep 2016 | $30.84 M(-75.4%) | -$4.38 M(+594.3%) | $30.84 M(-21.7%) |
| Jun 2016 | - | -$631.00 K(+669.5%) | $39.41 M(-6.2%) |
| Mar 2016 | - | -$82.00 K(-100.2%) | $42.03 M(-53.8%) |
| Dec 2015 | - | $35.94 M(+758.7%) | $90.89 M(-27.6%) |
| Sep 2015 | $125.46 M(+550.5%) | $4.18 M(+110.1%) | $125.46 M(+8.0%) |
| Jun 2015 | - | $1.99 M(-95.9%) | $116.19 M(-22.1%) |
| Mar 2015 | - | $48.77 M(-30.8%) | $149.14 M(+56.7%) |
| Dec 2014 | - | $70.51 M(-1486.4%) | $95.16 M(+393.4%) |
| Sep 2014 | $19.29 M(+99.7%) | -$5.09 M(-114.6%) | $19.29 M(-3.3%) |
| Jun 2014 | - | $34.94 M(-772.0%) | $19.94 M(-204.2%) |
| Mar 2014 | - | -$5.20 M(-3.1%) | -$19.13 M(+8.3%) |
| Dec 2013 | - | -$5.37 M(+21.0%) | -$17.67 M(-283.0%) |
| Sep 2013 | $9.66 M(-54.9%) | -$4.43 M(+7.4%) | $9.66 M(-3.8%) |
| Jun 2013 | - | -$4.13 M(+10.5%) | $10.04 M(-5.9%) |
| Mar 2013 | - | -$3.74 M(-117.0%) | $10.67 M(-77.1%) |
| Dec 2012 | - | $21.96 M(-642.1%) | $46.52 M(+117.4%) |
| Sep 2012 | $21.40 M(-19.2%) | -$4.05 M(+15.7%) | $21.40 M(-0.3%) |
| Jun 2012 | - | -$3.50 M(-110.9%) | $21.46 M(-14.0%) |
| Mar 2012 | - | $32.11 M(-1116.5%) | $24.96 M(-449.2%) |
| Dec 2011 | - | -$3.16 M(-20.8%) | -$7.15 M(+79.2%) |
| Sep 2011 | $26.47 M(+241.7%) | -$3.99 M | -$3.99 M |
| Sep 2010 | $7.75 M | - | - |
FAQ
- What is Enanta Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual EBIT year-on-year change?
- What is Enanta Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly EBIT year-on-year change?
- What is Enanta Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM EBIT year-on-year change?
What is Enanta Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ENTA is -$106.85 M
What is the all time high annual EBIT for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual earnings before interest & taxes is $125.46 M
What is Enanta Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ENTA annual earnings before interest & taxes has changed by +$19.00 M (+15.10%)
What is Enanta Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ENTA is -$26.61 M
What is the all time high quarterly EBIT for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly earnings before interest & taxes is $70.51 M
What is Enanta Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ENTA quarterly earnings before interest & taxes has changed by -$239.00 K (-0.91%)
What is Enanta Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ENTA is -$106.85 M
What is the all time high TTM EBIT for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM earnings before interest & taxes is $149.14 M
What is Enanta Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ENTA TTM earnings before interest & taxes has changed by +$19.00 M (+15.10%)